GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Magnasense AB (OSTO:MAGNA) » Definitions » FCF Margin %

Magnasense AB (OSTO:MAGNA) FCF Margin % : 0.00% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magnasense AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Magnasense AB's Free Cash Flow for the three months ended in Dec. 2024 was kr-2.13 Mil. Magnasense AB's Revenue for the three months ended in Dec. 2024 was kr0.00 Mil. Therefore, Magnasense AB's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Magnasense AB's current FCF Yield % is -221.43%.

The historical rank and industry rank for Magnasense AB's FCF Margin % or its related term are showing as below:


During the past 6 years, the highest FCF Margin % of Magnasense AB was -814.79%. The lowest was -51847.83%. And the median was -2875.85%.

OSTO:MAGNA's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -3.58
* Ranked among companies with meaningful FCF Margin % only.


Magnasense AB FCF Margin % Historical Data

The historical data trend for Magnasense AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magnasense AB FCF Margin % Chart

Magnasense AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Margin %
Get a 7-Day Free Trial - -814.79 -2,875.85 -51,847.83 -

Magnasense AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,130,400.00 - - - -

Competitive Comparison of Magnasense AB's FCF Margin %

For the Medical Devices subindustry, Magnasense AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magnasense AB's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Magnasense AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Magnasense AB's FCF Margin % falls into.


;
;

Magnasense AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Magnasense AB's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-27.68/0
= %

Magnasense AB's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-2.134/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magnasense AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Magnasense AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Magnasense AB Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.

Magnasense AB Headlines

No Headlines